X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8376) 8376
Book Chapter (44) 44
Publication (20) 20
Dissertation (19) 19
Conference Proceeding (6) 6
Magazine Article (2) 2
Book / eBook (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
everolimus (6593) 6593
humans (5738) 5738
female (3246) 3246
male (3028) 3028
sirolimus - analogs & derivatives (2819) 2819
middle aged (2456) 2456
oncology (2268) 2268
aged (2033) 2033
treatment outcome (1916) 1916
cardiac & cardiovascular systems (1388) 1388
adult (1344) 1344
sirolimus - therapeutic use (1340) 1340
cancer (1204) 1204
drug-eluting stents (1203) 1203
sirolimus - administration & dosage (1188) 1188
transplantation (1078) 1078
rapamycin (1054) 1054
sirolimus (1035) 1035
surgery (966) 966
animals (963) 963
immunosuppressive agents - therapeutic use (955) 955
tor serine-threonine kinases - antagonists & inhibitors (936) 936
antineoplastic agents - therapeutic use (899) 899
care and treatment (857) 857
mtor (841) 841
mammalian target (827) 827
time factors (802) 802
sirolimus - pharmacology (747) 747
sunitinib (727) 727
analysis (699) 699
efficacy (699) 699
everolimus - administration & dosage (699) 699
metastasis (682) 682
everolimus - therapeutic use (662) 662
follow-up studies (647) 647
risk factors (646) 646
therapy (642) 642
pharmacology & pharmacy (641) 641
carcinoma, renal cell - drug therapy (622) 622
sirolimus - adverse effects (618) 618
kidney neoplasms - drug therapy (615) 615
survival (615) 615
tumors (615) 615
prospective studies (600) 600
trial (594) 594
percutaneous coronary intervention (590) 590
retrospective studies (581) 581
thrombosis (573) 573
stents (548) 548
prosthesis design (546) 546
angiogenesis inhibitors (538) 538
immunosuppressive agents - administration & dosage (520) 520
stent (518) 518
immunology (511) 511
medicine & public health (502) 502
abridged index medicus (491) 491
chemotherapy (488) 488
aged, 80 and over (487) 487
research (487) 487
patients (477) 477
cell line, tumor (475) 475
clinical trials (473) 473
prognosis (469) 469
antineoplastic combined chemotherapy protocols - therapeutic use (467) 467
cyclosporine (467) 467
tor serine-threonine kinases - metabolism (466) 466
immunosuppressive agents - adverse effects (460) 460
coronary artery disease - therapy (455) 455
interferon-alpha (453) 453
kidney transplantation (452) 452
absorbable implants (446) 446
tacrolimus (442) 442
implantation (439) 439
renal cell carcinoma (439) 439
urology & nephrology (438) 438
breast cancer (436) 436
double-blind (434) 434
mice (430) 430
coronary angiography (429) 429
sorafenib (427) 427
safety (426) 426
immunosuppressive agents - pharmacology (413) 413
health aspects (407) 407
disease-free survival (405) 405
expression (402) 402
outcomes (394) 394
temsirolimus (390) 390
cardiovascular agents - administration & dosage (384) 384
drug therapy (381) 381
kidney neoplasms - pathology (379) 379
drug therapy, combination (365) 365
mtor inhibitors (365) 365
multicenter (358) 358
everolimus - pharmacology (354) 354
antineoplastic agents - pharmacology (353) 353
signal transduction - drug effects (353) 353
everolimus - adverse effects (352) 352
targeted therapy (350) 350
immunosuppression (348) 348
cardiovascular (346) 346
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8072) 8072
French (115) 115
Japanese (105) 105
German (85) 85
Spanish (60) 60
Russian (44) 44
Chinese (13) 13
Italian (11) 11
Hungarian (9) 9
Korean (9) 9
Portuguese (9) 9
Polish (7) 7
Czech (6) 6
Turkish (3) 3
Dutch (2) 2
Slovenian (2) 2
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The journal of clinical endocrinology and metabolism, ISSN 0021-972X, 2017, Volume 102, Issue 2, pp. 698 - 707
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2017, Volume 35, Issue 34, pp. 3851 - 3858
Purpose Combination treatment with immune checkpoint inhibitors has shown enhanced antitumor activity compared with monotherapy in tumor types such as... 
EVEROLIMUS | ONCOLOGY | Index Medicus
Journal Article
Journal Article
European Urology, ISSN 0302-2838, 2017, Volume 72, Issue 6, pp. 962 - 971
Journal Article
Journal Article
Clinical cancer research, ISSN 1557-3265, 2016, Volume 22, Issue 22, pp. 5461 - 5471
Journal Article
Journal of the American Society of Nephrology, ISSN 1533-3450, 2018, Volume 29, Issue 7, pp. 1979 - 1991
Journal Article
Molecular oncology, ISSN 1574-7891, 2017, Volume 11, Issue 8, pp. 1007 - 1022
textabstractMedullary thyroid cancer (MTC) is a tumor highly resistant to chemo- and radiotherapy. Drug resistance can be induced by epigenetic changes such as... 
NGFR | Neurotrophin pathway | Everolimus | Medullary thyroid cancer | MTOR | 5-aza-2'-deoxycytidine | medullary thyroid cancer | mTOR | neurotrophin pathway | everolimus | 5‐aza‐2′‐deoxycytidine | 5-aza-2′-deoxycytidine | 5-aza-2 '-deoxycytidine | CANCER-CELLS | NEUROTROPHIN RECEPTOR | NEUROENDOCRINE TUMORS | PANCREATIC-CANCER | MEDIATED APOPTOSIS | NERVE GROWTH-FACTOR | IN-VITRO | ONCOLOGY | SIGNALING PATHWAY | COLORECTAL-CANCER | TUMOR-SUPPRESSOR | Carcinoma, Neuroendocrine - metabolism | Genome-Wide Association Study | Everolimus - pharmacology | Neoplasm Proteins - biosynthesis | Carcinoma, Neuroendocrine - drug therapy | Humans | Azacitidine - analogs & derivatives | Azacitidine - agonists | Drug Synergism | Azacitidine - pharmacology | Thyroid Neoplasms - drug therapy | Carcinoma, Neuroendocrine - pathology | Gene Expression Regulation, Neoplastic - drug effects | Everolimus - agonists | Thyroid Neoplasms - metabolism | Thyroid Neoplasms - pathology | TOR protein | Bax protein | p53 Protein | Cytotoxicity | AKT protein | Genomes | Radiation therapy | Tumor cell lines | Drug resistance | Western blotting | 1-Phosphatidylinositol 3-kinase | Thyroid carcinoma | Signal transduction | Cell growth | Thyroid cancer | Nerve growth factor receptors | DNA methylation | Extracellular matrix | Mutation | Neuroendocrine tumors | Thyroid | Apoptosis
Journal Article
Cancer discovery, ISSN 2159-8290, 2014, Volume 4, Issue 5, pp. 546 - 553
Journal Article
The Journal of clinical investigation, ISSN 0021-9738, 2010, Volume 120, Issue 8, pp. 2858 - 2866
Journal Article